Ken Baumann has been diagnosed with gastrointestinal illness Crohn's disease.
Source: http://www.femalefirst.co.uk/entertainment/Ken+Baumann-247937.html
Cristina Dumitru Daisy Fuentes Dania Ramirez Danica Patrick Daniella Alonso Danneel Harris Deanna Russo Denise Richards
I was sad to learn that Ken Baumann has been diagnosed with Crohn’s disease. It is such a painful condition, and he is so young. But I have some information that could help him.
ReplyDeleteThere have been two studies that show that a little-known, inexpensive, off-label medication called Low Dose Naltrexone (LDN) can be of tremendous help to sufferers of this disease. In fact, a 2007 study by Jill Smith, MD et al, titled “Low-dose naltrexone therapy improves active Crohn's disease,” and published in “American Journal of Gastroenterology,” concluded that “eighty-nine percent of patients [treated with Low Dose Naltrexone] exhibited a response to therapy and 67% achieved a remission.” And another study four years later came to a similar conclusion, stating that there was “at least a 70-point decline in CDAI scores [in patients treated with LDN] compared to 40% of placebo-treated patients.” (NOTE: CDAI scores refer to the Crohn's Disease Activity Index score.) This second study was published in the online journal “Digestive Diseases and Sciences.” You may read about these two studies in Pub Med at http://www.ncbi.nlm.nih.gov/pubmed/17222320 and http://www.ncbi.nlm.nih.gov/pubmed/21380937.
It is a shame that more doctors (and especially gastroenterologists) who treat patients with Crohn’s disease don’t know about Low Dose Naltrexone, since both of these studies were published in their own professional journals.
I learned about Low Dose Naltrexone when writing my book, “Honest Medicine: Effective, Time-Tested, Inexpensive Treatments for Life-Threatening Diseases.” LDN is one of the book’s featured treatments.
Many patients have been helped by this very inexpensive, non-toxic treatment. I hope that Ken Baumann will read this comment and will do his own research about LDN. I would be happy to help him in any way I can.
Julia Schopick
HonestMedicine.com